UK markets close in 5 hours 13 minutes

Salarius Pharmaceuticals, Inc. (SLRX)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
0.4641-0.0197 (-4.07%)
At close: 04:00PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Cash flows from operating activities
Net income
-8,917
-12,543
-31,608
-12,768
-7,352
-
Depreciation & amortisation
9.489
10.051
6.677
19.183
18.058
-
Stock-based compensation
399.001
524.838
796.803
559.044
319.391
-
Change in working capital
-2,652
-968.333
2,370
2,035
-3,038
-
Accounts receivable
-
-
-
-
0
0.69
Inventory
-
-
-
-
0
1.169
Accounts payable
-2,772
-2,255
1,313
-310.66
-2.782
-
Other working capital
-11,031
-12,846
-19,095
-10,200
-10,314
-
Other non-cash items
-
-
1,988
-
-
-
Net cash provided by operating activities
-11,031
-12,846
-17,595
-10,200
-10,311
-
Cash flows from investing activities
Investments in property, plant and equipment
-
-
-1,500
-
-2.6
-
Net cash used for investing activities
-
0
-1,500
0
-2.6
-
Cash flows from financing activities
Debt repayment
-453.705
-280.917
0
-477.028
-974.435
-
Common stock issued
6,584
6,921
1,987
27,288
14,799
-
Common stock repurchased
-
-
-
-
-
0
Dividends paid
-
-
-
-
0
-133.594
Net cash used provided by (used for) financing activities
6,130
6,640
1,987
28,296
17,694
-
Net change in cash
-4,900
-6,207
-17,108
18,096
7,380
-
Cash at beginning of period
9,274
12,106
29,214
11,119
3,739
-
Cash at end of period
4,373
5,900
12,106
29,214
11,119
-
Free cash flow
Operating cash flow
-11,031
-12,846
-17,595
-10,200
-10,311
-
Capital expenditure
-
-
-1,500
-
-2.6
-
Free cash flow
-11,031
-12,846
-19,095
-10,200
-10,314
-